Evidence map›Paper›PMID 25242873›Full record

ArticleMediators of inflammation2014

Purine-metabolizing ectoenzymes control IL-8 production in human colon HT-29 cells.

Fariborz Bahrami, Filip Kukulski, Joanna Lecka, Alain Tremblay, Julie Pelletier, Liliana Rockenbach, Jean Sévigny

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. P2YJournal of immunology research · 2026
    Article
  2. Article
  3. Article
  4. The Expression Level of ABCC6 Transporter in Colon Cancer Cells Correlates with the Activation of Different Intracellular Signaling Pathways.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Article
  5. Article
  6. The Role of Interleukins in Colorectal Cancer.International journal of biological sciences · 2020
    Review
  7. Investigation ofInfectious agents and cancer · 2020
    Article
  8. P2YFrontiers in pharmacology · 2018
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fariborz BahramiDépartement de Microbiologie-Infectiologie et d'Immunologie, Faculté de Médecine, Université Laval, Québec, QC, Canada G1V 0A6 ; Centre de Recherche du CHU de Québec, 2705 Boulevard Laurier, Local T1-49, Québec, QC, Canada G1V 4G2.ORCID 0000-0001-9561-415X
Filip KukulskiDépartement de Microbiologie-Infectiologie et d'Immunologie, Faculté de Médecine, Université Laval, Québec, QC, Canada G1V 0A6 ; Centre de Recherche du CHU de Québec, 2705 Boulevard Laurier, Local T1-49, Québec, QC, Canada G1V 4G2.
Joanna LeckaDépartement de Microbiologie-Infectiologie et d'Immunologie, Faculté de Médecine, Université Laval, Québec, QC, Canada G1V 0A6 ; Centre de Recherche du CHU de Québec, 2705 Boulevard Laurier, Local T1-49, Québec, QC, Canada G1V 4G2.ORCID 0000-0002-7127-4434
Alain TremblayCentre de Recherche du CHU de Québec, 2705 Boulevard Laurier, Local T1-49, Québec, QC, Canada G1V 4G2.
Julie PelletierCentre de Recherche du CHU de Québec, 2705 Boulevard Laurier, Local T1-49, Québec, QC, Canada G1V 4G2.
Liliana RockenbachDépartement de Microbiologie-Infectiologie et d'Immunologie, Faculté de Médecine, Université Laval, Québec, QC, Canada G1V 0A6 ; Centre de Recherche du CHU de Québec, 2705 Boulevard Laurier, Local T1-49, Québec, QC, Canada G1V 4G2.
Jean SévignyDépartement de Microbiologie-Infectiologie et d'Immunologie, Faculté de Médecine, Université Laval, Québec, QC, Canada G1V 0A6 ; Centre de Recherche du CHU de Québec, 2705 Boulevard Laurier, Local T1-49, Québec, QC, Canada G1V 4G2.
Centre hospitalier universitaire de Québec · CA

Funding

Canadian Institutes of Health Research MOP-93683
6 · The paper itself

Abstract

Interleukin-8 (IL-8) plays key roles in both chronic inflammatory diseases and tumor modulation. We previously observed that IL-8 secretion and function can be modulated by nucleotide (P2) receptors. Here we investigated whether IL-8 release by intestinal epithelial HT-29 cells, a cancer cell line, is modulated by extracellular nucleotide metabolism. We first identified that HT-29 cells regulated adenosine and adenine nucleotide concentration at their surface by the expression of the ectoenzymes NTPDase2, ecto-5'-nucleotidase, and adenylate kinase. The expression of the ectoenzymes was evaluated by RT-PCR, qPCR, and immunoblotting, and their activity was analyzed by RP-HPLC of the products and by detection of Pi produced from the hydrolysis of ATP, ADP, and AMP. In response to poly (I:C), with or without ATP and/or ADP, HT-29 cells released IL-8 and this secretion was modulated by the presence of NTPDase2 and adenylate kinase. Taken together, these results demonstrate the presence of 3 ectoenzymes at the surface of HT-29 cells that control nucleotide levels and adenosine production (NTPDase2, ecto-5'-nucleotidase and adenylate kinase) and that P2 receptor-mediated signaling controls IL-8 release in HT-29 cells which is modulated by the presence of NTPDase2 and adenylate kinase.

Indexed as

5'-NucleotidaseAdenosine TriphosphatasesAdenylate KinaseHT29 CellsHumansInterleukin-8Polymerase Chain ReactionPurines5'-NucleotidaseAdenosine TriphosphatasesAdenylate KinaseectoATPaseInterleukin-8purinePurines

Identifiers

PMID25242873
PMCPMC4158428
OpenAlexW2109616549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.